Hetta, H.F.; Alatawi, Y.; Alanazi, F.E.; Alattar, A.; Alshaman, R.; Alshareef, H.; Alatawi, Z.; Alatawi, M.S.; Albalawi, J.H.; Alosaimi, G.A.;
et al. Evaluating the Safety and Efficacy of PD-1 Inhibitors in HIV Patients Diagnosed with Lung Cancer: A Systematic Review. Pharmaceuticals 2025, 18, 1654.
https://doi.org/10.3390/ph18111654
AMA Style
Hetta HF, Alatawi Y, Alanazi FE, Alattar A, Alshaman R, Alshareef H, Alatawi Z, Alatawi MS, Albalawi JH, Alosaimi GA,
et al. Evaluating the Safety and Efficacy of PD-1 Inhibitors in HIV Patients Diagnosed with Lung Cancer: A Systematic Review. Pharmaceuticals. 2025; 18(11):1654.
https://doi.org/10.3390/ph18111654
Chicago/Turabian Style
Hetta, Helal F., Yasser Alatawi, Fawaz E. Alanazi, Abdullah Alattar, Reem Alshaman, Hanan Alshareef, Zinab Alatawi, Majd S. Alatawi, Jumana H. Albalawi, Ghadeer A. Alosaimi,
and et al. 2025. "Evaluating the Safety and Efficacy of PD-1 Inhibitors in HIV Patients Diagnosed with Lung Cancer: A Systematic Review" Pharmaceuticals 18, no. 11: 1654.
https://doi.org/10.3390/ph18111654
APA Style
Hetta, H. F., Alatawi, Y., Alanazi, F. E., Alattar, A., Alshaman, R., Alshareef, H., Alatawi, Z., Alatawi, M. S., Albalawi, J. H., Alosaimi, G. A., Sayad, R., & Nageeb, W. M.
(2025). Evaluating the Safety and Efficacy of PD-1 Inhibitors in HIV Patients Diagnosed with Lung Cancer: A Systematic Review. Pharmaceuticals, 18(11), 1654.
https://doi.org/10.3390/ph18111654
